Search

everythinglearnresearchcommunity

for

Search:↓

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Hair loss can cause significant emotional and psychological distress.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

More research, better treatments, and public education are needed for dermatological conditions in people of African descent.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Chemical relaxers may cause scarring alopecia in black women.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

The patient responded well to treatment with no disease progression.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

PRP therapy is a safe and effective treatment for hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Chemical hair straighteners can cause scalp and hair damage, but long-term effects are unclear.

Dupilumab can cause rare side effects like a rash on the face and neck.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A rare skin condition causing scarring was successfully treated with topical erythromycin and benzoyl peroxide.

A 13-year-old boy with a rare scalp condition improved significantly with isotretinoin, minoxidil, oral steroids, and antiseptic shampoo.

A scarring hair loss condition mainly affects middle-aged women of African descent, impacting their quality of life, with treatments more effective when started early.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.